NASDAQ: ILMNIllumina Inc Stock Ownership - Who owns Illumina?
Insider buying vs selling
Have Illumina Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Everett Cunningham | SVP Chief Commercial Officer | 2025-07-05 | 4,248 | $97.15 | $412.69kSell |
| Scott B. Ullem | Director | 2025-06-30 | 307 | $81.20 | $24.93kBuy |
| Caroline Dorsa | Director | 2025-05-16 | 1,070 | $83.62 | $89.47kSell |
| Scott B. Ullem | Director | 2025-05-16 | 1,070 | $83.62 | $89.47kSell |
| Jacob Thaysen | Chief Executive Officer | 2025-05-13 | 804 | $81.56 | $65.57kBuy |
| Jacob Thaysen | Chief Executive Officer | 2025-05-13 | 100 | $82.26 | $8.23kBuy |
| Jacob Thaysen | Chief Executive Officer | 2025-05-13 | 4,946 | $80.70 | $399.14kBuy |
| Ankur Dhingra | SVP Chief Financial Officer | 2025-05-12 | 6,100 | $81.21 | $495.38kBuy |
| Jacob Thaysen | Chief Executive Officer | 2025-05-12 | 200 | $82.66 | $16.53kBuy |
| Jacob Thaysen | Chief Executive Officer | 2025-05-12 | 1,400 | $81.54 | $114.16kBuy |
ILMN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ILMN insiders and whales buy or sell their stock.
ILMN Shareholders
What type of owners hold Illumina Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 12.59% | 19,357,874 | $1.94B | Institution |
| Capital World Investors | 10.83% | 16,645,308 | $1.67B | Institution |
| Vanguard Group Inc | 9.86% | 15,153,033 | $1.52B | Institution |
| Keith A. Meister | 4.99% | 7,663,421 | $767.19M | Insider |
| State Street Corp | 3.65% | 5,617,270 | $562.34M | Institution |
| Sessa Capital IM LP | 3.07% | 4,722,874 | $472.81M | Institution |
| Wcm Investment Management LLC | 2.88% | 4,426,471 | $443.13M | Institution |
| Loomis Sayles Co L P | 2.75% | 4,225,529 | $423.02M | Institution |
| Corvex Management LP | 2.49% | 3,829,608 | $383.38M | Institution |
| Aqr Capital Management LLC | 2.14% | 3,295,880 | $329.95M | Institution |
ILMN vs Diagnostic & Research Stocks
Illumina Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.